One-year outcome of a prospective trial stopping dual antiplatelet therapy at 3 months after everolimus-eluting cobalt-chromium stent implantation: ShortT and OPtimal duration of Dual AntiPlatelet Therapy after everolimus-eluting cobalt-chromium stent (STOPDAPT) trial

There has been no previous prospective study evaluating dual antiplatelet therapy (DAPT) duration shorter than 6 months after cobalt-chromium everolimus-eluting stent (CoCr-EES) implantation. STOPDAPT trial is a prospective multi-center single-arm study evaluating 3-month DAPT duration after CoCr-EE...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cardiovasc Interv Ther
Main Authors: Natsuaki, Masahiro, Morimoto, Takeshi, Yamamoto, Erika, Shiomi, Hiroki, Furukawa, Yutaka, Abe, Mitsuru, Nakao, Koichi, Ishikawa, Tetsuya, Kawai, Kazuya, Yunoki, Kei, Shimizu, Shogo, Akao, Masaharu, Miki, Shinji, Yamamoto, Masashi, Okada, Hisayuki, Hoshino, Kozo, Kadota, Kazushige, Morino, Yoshihiro, Igarashi, Keiichi, Tanabe, Kengo, Kozuma, Ken, Kimura, Takeshi
Formato: Artigo
Idioma:Inglês
Publicado em: Springer Japan 2015
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4923071/
https://ncbi.nlm.nih.gov/pubmed/26518420
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12928-015-0366-9
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados